Now get all the training you need – all in one place, and all for one low price!
The FDAnews Webinar Training Pass program gives you year-round unrestricted access to any of the hundreds of webinars listed below. These training programs feature top consultants, expert speakers and FDA officials.
PLUS, subscribers get automatic access to all our new training programs for the next 12 months – that’s more than 50 new programs a year!
If you are already a Training Pass member login below and then scroll down to view the list in date order or narrow your search by keyword or category. Viewing the webinar is easy… simply identify the webinar you want to watch, click on the title and the video will begin. If you would like to view or download the presentation materials separately from the video click the "Download Presentation" link.
BUY NOW 1-Year Unlimited Access $1,297
Search by keyword, speaker name or just by category (drug, device or clinical) and you'll find all you need.
If you have any questions or are having any problems please give us a call on 703.538.7600 or email customer service.
Webinar Training Pass
Recorded on: June 25, 2020
Description: Clinical trial management experts Irina Petrova and Anna Yanaeva discuss reasons trial spending might exceed proposed costs and how to navigate shifting study needs while maintaining a budget. They cover:
- Determining expendable costs and expenses;
- Case studies on successful budget planning;
- Statistics on exceeding, meeting and running below budget; and
- Focusing on programmatic goals to direct spending.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Irina Petrova, Director of Clinical Operations and Anna Yanaeva, Head of Business Development, OCT Clinical
Recorded on: June 24, 2020
Description: Device regulatory expert Tina Krenc presents best practices and guidance to meet the revised risk management requirements in ISO 14971:2019. She discusses:
- How regulators and auditors will look at things differently;
- Procedural changes to make in addition to changing SOP references; and
- Rethinking the way you’ve been doing risk management.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Tina Krenc, Principal Consultant, KTA Compliance Consulting
Recorded on: June 23, 2020
Description: Pharmacovigilance expert Catherine Baldridge discusses REMS critical components as well as the importance of advanced planning and proper resource allocation to prepare you for the ultimate success of your REMS programs. She covers:
- Tools to have in place and topics to discuss when bringing on a contract research organization (CRO) partner and/or developing an in-house program;
- The recommended quality and compliance processes you need to consider during an implementation, including audit recommendations and legal considerations; and
- The importance and value of cross-functional engagement when developing and implementing a program, such as collaboration with your commercial and supply teams.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Catherine Baldridge, Owner/Founder, Essential Pharmacovigilance
Medical Device Safety in the Magnetic Resonance Environment: CDRH’s Recent Draft Guidance Explained
80 minutes
Recorded on: June 18, 2020
Description: Device expert Dan O’Leary explains how the draft guidance considers hazards in the MR environment, what to include in a hazard analysis and which standards must be followed to demonstrate device safety. He covers:
- How to best document your results;
- The importance of accurate safety labeling;
- The application of ISO 14971:2019 to MR environment hazards; and
- Product safety standards in the context of ISO 14971:2019.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Dan O’Leary, President, Ombu Enterprises
Recorded on: June 16, 2020
Description: A team of legal experts shares practical guidelines and tips on maintaining compliance during the COVID-19 pandemic while also discussing how to manage any potential investigations from regulatory bodies. They cover:
- Identifying concerns and risk;
- Developing investigation protocols;
- Implementing audit methods; and
- Prioritizing investigation and compliance tasks.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Gail Rodgers, partner, Nancy Sims, of counsel, Mason Hubbard, associate, and Adam Pié, associate, DLA Piper
Recorded on: June 10, 2020
Description: Recall experts Seth Mailhot and Tom Brockhaus identify the exceptions, required records and various reporting methods and their issues to help you ensure any corrections, removals, recalls or closures have the minimum impact on your business. They cover:
- The benefits and methods of data cleansing mail files, such as Coding Accuracy Support System (CASS) and National Change of Address (NCOA) to avoid wasting resources and to increase delivery rates of important recall communications;
- The differences between first-class and certified mail and considerations on what method to use;
- Understanding the different approaches to conducting effectiveness checks, including use of automated telephony feedback systems; and
- The importance of training call center agents on topics such as recall sensitivity, handling of escalations and identification of incidents.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Seth Mailhot, partner, Husch Blackwell, and Tom Brockhaus, senior vice president, Recall Results
Medical Devices and Digital Health After COVID-19: Implications for the Industry and Your Business
59 minutes
Recorded on: June 9, 2020
Description: Representatives of medical device CRO MCRA discuss ways that the regulatory, clinical and reimbursement pathways will change and how you should be planning for the post-COVID-19 world. They cover:
- Impact of COVID-19 on clinical design and reimbursement;
- Rise of telehealth and other digital health technologies and how implementation could impact cardiovascular clinical studies;
- Effect of the financial crunch on clinical study design and how to reduce cost, timing and burden; and
- Advantages and limitations in creating virtual clinical studies.
Presentation: Download the presentation
Transcript: Download the transcript
Speakers: Glenn Stiegman, Senior Vice President, Nicole Batista, Associate Director, Tonya Dowd, Vice President, Michael John, Vice President, and Iman Ahmad, Director of Clinical Affairs, MCRA
Pharmaceutical Social Media Advertising: Expand Your Reach and Prevent Regulatory Mistakes
66 minutes
Recorded on: June 4, 2020
Description: Healthcare market research analyst Fred Church shares strategies for creating, designing, planning, managing and evaluating social media performance to avoid costly warning letters and untitled letters. He discusses:
- Which platforms are the best fit for different therapeutic products;
- Whether branded or unbranded content is more appropriate for specific products and focus areas;
- Ways to use market research to test and evaluate social media, including a methodology for forecasting return on investment prior to launch; and
- What experts expect to see on social media as platforms grow and what it means for pharmaceutical advertising.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Fred Church, Founder, Format Analytics
Recorded on: June 3, 2020
Description: Life sciences litigator Nicholas Mitrokostos discusses the new wave of expiring regulatory exclusivities regarding biologics and how the FDA is managing new biosimilar product applications. He covers:
- The deemed-to-be-a-license provision;
- Demonstrating interchangeability with a reference product;
- Clinical immunogenicity considerations for biosimilar and interchangeable insulin products; and
- Promotions, labeling, and advertising of biologic and biosimilar products.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Nicholas Mitrokostas, Partner, Goodwin Procter
Recorded on: June 2, 2020
Description: Device regulatory expert Jon Gimbel explains what you must know to meet EU-MDR’s and EU-IVDR’s requirements for clinical and performance evaluation reports. He discusses:
- Ideas for recommended report structures;
- How literature searches can be used within these evaluations; and
- Common notified body findings and pitfalls, including those related to equivalence and measurable objectives.
Presentation: Download the presentation
Transcript: Download the transcript
Speaker: Jon Gimbel, Executive Director, Regulatory and Quality Solutions
